Envelope-engineered lentiviruses that address the receptor mismatch behind poor transduction of resting hematopoietic cells — LVh34 for human CD34⁺ HSC and LVh45 for human CD45⁺ leukocytes — plus retroviral vectors for mouse primary T cells and bone-marrow stem cells.
| Product | Catalogue | Size options | List price | Promo price | Manual | COA |
|---|---|---|---|---|---|---|
| CD34-targeted Lentivirus for Human HSC | LVh34 | : 100 μLx10,Titer >1e+7 TU/mL | Inquire | Inquire | Manual | — |
| CD45-targeted Lentivirus for Human Leukocytes | LVh45 | : 100 μLx10,Titer >1e+7 TU/mL | Inquire | Inquire | Manual | — |
| Mouse CD3-targeted Lentivirus (for mouse T cells) | LVm3 | : 100 μLx10,Titer >1e+7 TU/mL | Inquire | Inquire | Manual | — |
| Mouse CD3-targeted Lentivirus (for mouse T cells) | LVm45 | : 100 μLx10,Titer >1e+7 TU/mL | Inquire | Inquire | Manual | — |
| Retroviral Knockdown / Overexpression Vectors (mouse primary T cells, bone-marrow stem cells) | RVDZ | : 100 μLx10,Titer >1e+7 TU/mL | Inquire | Inquire | — | — |
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.